TrianglePUBLICATIONS · 17602086
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2007 Jul 1
- First author
- Mutch DG
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Mutch DG
- type
- Author
- name
- Orlando M
- type
- Author
- name
- Goss T
- type
- Author
- name
- Teneriello MG
- type
- Author
- name
- Gordon AN
- type
- Author
- name
- McMeekin SD
- type
- Author
- name
- Wang Y
- type
- Author
- name
- Scribner DR Jr
- type
- Author
- name
- Marciniack M
- type
- Author
- name
- Naumann RW
- type
- Author
- name
- Secord AA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Mutch DG
- type
- Author
- name
- Orlando M
- type
- Author
- name
- Goss T
- type
- Author
- name
- Teneriello MG
- type
- Author
- name
- Gordon AN
- type
- Author
- name
- McMeekin SD
- type
- Author
- name
- Wang Y
- type
- Author
- name
- Scribner DR Jr
- type
- Author
- name
- Marciniack M
- type
- Author
- name
- Naumann RW
- type
- Author
- name
- Secord AA
- type
- Author
- bibliography ids
- nci-bib-fd158ffaa221d94a7f9b9964
- book metadata
- content sha256
- 4f682e9f1c446b736c93522caf6952b89cc1934a24c12e817c1ed8c224ef8be1
- document type
- citation
- dois
- 10.1200/JCO.2006.09.6735
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17602086
- immutable id
- pubmed:17602086@4f682e9f1c446b736c93522caf6952b89cc1934a24c12e817c1ed8c224ef8be1
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2811-8
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 17602086
- provenance
- batch id
- de363a11f4b1613edab0
- provider
- NCBI PubMed ESummary
- record sha256
- 7255c4a830c7456919bdf3d414ed225cf17410a72f439cea6c5740c59ce63dfa
- response sha256
- a83f066085229c55d3d0ec880c129c835ac872440e73f5fc2b7131ecfb2a254f
- retrieved at
- 2026-09-09T23:46:14.107379+00:00
- publication date
- display
- 2007 Jul 1
- precision
- day
- year
- 2007
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
Preserved source evidence · Not medical advice